MARKET

CASI

CASI

Casi Pharmaceuticals Inc
NASDAQ
0.9783
+0.0383
+4.07%
After Hours: 0.9404 -0.0379 -3.87% 17:48 12/04 EST
OPEN
0.9633
PREV CLOSE
0.9400
HIGH
0.9857
LOW
0.9400
VOLUME
26.54K
TURNOVER
--
52 WEEK HIGH
4.050
52 WEEK LOW
0.9300
MARKET CAP
20.10M
P/E (TTM)
-0.3278
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CASI last week (1124-1128)?
Weekly Report · 3d ago
Weekly Report: what happened at CASI last week (1117-1121)?
Weekly Report · 11/24 10:37
CASI Pharmaceuticals Appoints James Huang as Non-Executive Chairman
Reuters · 11/19 14:00
Weekly Report: what happened at CASI last week (1110-1114)?
Weekly Report · 11/17 10:38
CASI Pharmaceuticals Reports Q3 2025 Results Amid Nasdaq Delisting Appeal
TipRanks · 11/14 22:25
CASI Pharmaceuticals GAAP EPS of -$0.67, revenue of $3.07M
Seeking Alpha · 11/14 21:48
CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens
Reuters · 11/14 21:17
CASI Pharmaceuticals Reports Third Quarter Revenue of $3.1 Million and Net Loss of $10.9 Million
Reuters · 11/14 21:05
More
About CASI
CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing, and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. Its commercial product, EVOMELA, is an intravenous formulation of melphalan commercialized by Acrotech in the multiple myeloma treatment setting in the United States. Its pipeline products include CNCT19 (CD19 CAR-T), BI-1206 (anti- FcYRIIB antibody), CB-5339 (VCP/p97 inhibitor), CID-103 (Anti-CD38 Mab), Thiotepa, and Octreotide LAI. The Company’s Food and Drug Administration (FDA)-approved generic products for the China market include Entecavir tablets, Tenofovir disoproxil fumarate (TDF) tablets, Cilostazol tablets-50mg, Cilostazol tablets-100mg, Ondansetron HCL tablets, and Tizanidine tablets.

Webull offers CASI Pharmaceuticals Inc stock information, including NASDAQ: CASI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CASI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CASI stock methods without spending real money on the virtual paper trading platform.